CDNA

Caredx

• TipRanks·03/09 10:25

  CareDx: Solid Near-Term Execution vs. Reimbursement Headwinds and Long-Dated Pipeline Upside Justify Hold Rating

• TipRanks·03/06 00:21

  CareDx Earnings Call Highlights Growth Amid Reimbursement Risks

• TipRanks·03/05 21:06

  CareDx announces launch of VANTx

• Reuters·03/05 21:01

  CareDx Chief Data and AI Officer Jing Huang to Introduce VANTx at Precision Medicine World Conference in Silicon Valley

• Reuters·02/27 21:01

  CareDx Awards 82,137 RSU Shares to 35 New Employees

• Reuters·02/27 21:01

  CAREDX ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

• Dow Jones·02/26 11:46

  CareDx Is Maintained at Buy by BTIG

• Benzinga·02/26 11:36

  BTIG Maintains Buy on CareDx, Raises Price Target to $26

• TipRanks·02/26 02:25

  CareDx: Strong Growth, Discounted Valuation, and Emerging Oncology Optionality Support Buy Rating

• TipRanks·02/26 01:20

  CareDx price target raised to $26 from $25 at BTIG

• Reuters·02/25 21:13

  CareDx Files Amended 8-K on Q4 and Full-Year 2025 Results

• Dow Jones·02/25 14:59

  CareDx Is Maintained at Equal-Weight by Wells Fargo

• Dow Jones·02/25 14:59

  CareDx Price Target Raised to $21.00/Share From $18.00 by Wells Fargo

• Benzinga·02/25 14:49

  Wells Fargo Maintains Equal-Weight on CareDx, Raises Price Target to $21

• TipRanks·02/25 14:20

  Analysts Offer Insights on Healthcare Companies: CareDx (CDNA) and Atai Beckley N.V. (ATAI)